about
Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patientsTracing the origin of disseminated tumor cells in breast cancer using single-cell sequencingA prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patientsmiRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsMethylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataUse of automated microscopy for the detection of disseminated tumor cells in bone marrow samples.Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer?Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes.Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsComparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant diseaseInternational study on inter-reader variability for circulating tumor cells in breast cancerMinimal residual disease in breast cancer.Combining gene signatures improves prediction of breast cancer survival.Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaNOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.Allele-specific copy number analysis of tumors.Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsDisseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyNeoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.The clinical impact of mean vessel size and solidity in breast carcinoma patients.Novel patterns of genome rearrangement and their association with survival in breast cancer.Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumorsThe prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patientsExpression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomasIntegrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingThe Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast CancerGefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.Circulating and disseminated tumor cells.Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes.A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survivalA mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamideNext-generation sequencing of disseminated tumor cells.Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.
P50
Q28305345-BCD99CC9-BEB7-4B17-B899-C7B9F8F1A400Q28396153-4EC08AE3-2BC1-4B3F-9E5B-9D840372FBBEQ28731800-53EE1039-E208-4F7E-A3E6-7626CC90AF3BQ28742532-E61B4B15-E2B2-496D-A093-25095B0C0C3DQ30488766-592506DB-6C70-4624-835C-ABDC375B3F04Q30587051-F3B822CA-A7E8-46DC-BF26-558B915CCA59Q30701696-08365983-4E8E-417C-8576-537A442D1AE6Q31099432-4A4FDC49-3C49-47AD-9BF8-D1A001102F79Q33236464-4A353B92-AE69-4D93-B8E1-8F5D1A6257C8Q33244907-C94CB521-AA91-4E3C-8279-EAA889B62E8FQ33358940-2F1311DB-BDB7-4039-BB95-AC14C3882F9DQ33628466-D34CB126-37AB-49C5-AD04-FA910F82218DQ33738688-AE06CE52-4740-426E-A1FA-5E5116F53690Q33743271-99FE1B9B-1B47-4C6F-A632-D999DB385CAAQ33851725-07EFBDC8-BD0D-46E1-B98B-A1E335AEC85DQ33854762-52671269-C2B4-414D-A2AA-C365776E30CCQ33911898-1EB1CC63-7B6A-4507-9F93-C401D1C333FBQ33921638-0642BBD2-E332-41D6-BEE8-5606E50AE022Q34165640-CDFB9C9E-B74C-40D2-B1EE-592286FFCC7CQ34196315-C97C03CF-B3A4-4701-A9A5-1B008E13C8EFQ34267035-1C928407-D37C-4595-9081-AD7E9BC898B2Q34468675-01A7214F-1088-4DE3-87ED-2A765D98B989Q34520174-DBEA9230-3949-4B13-9D5B-3B7831670A0AQ34940150-5EEFE313-E884-49A6-ADC1-0B6AD3CC36DFQ35022553-19BB23F9-87CB-4E95-99E9-24E2C93C0759Q35173695-0322787A-54DB-41A9-ACA4-75B0F159FAC0Q35204472-EC3D92EC-AE83-4F77-8E75-D64F829D8908Q35558100-D70CDAF0-5076-4258-8175-8CB04DFF7D9DQ35693944-8B25B15E-F533-448C-84F3-71A9F38D82F1Q35779345-0AFDE989-C9FF-41D9-A75E-8C2B99518064Q35804614-920A5603-127D-48C7-BD95-6F1A87C18E78Q35990886-0A8F7573-94D0-4E74-A0F4-66EC1929414CQ36065447-F66BCC1F-2FEB-41FF-BF26-1F52F9AAF201Q36465244-8064AD6C-B1FA-456E-B153-460F5ABA76FCQ36549817-791F9826-FA18-4530-9A37-4B978CF6EBC4Q36924468-8BC9094F-BC2E-4E6D-9B37-2E668C1C2DCDQ37229749-BA358FFF-5F61-428A-A508-92A02E1D5AFFQ37421423-44D7ECC8-828A-439C-AF06-9CA7AEE9596DQ37678826-F01C975A-EC0A-4B32-A6B3-D906A83448B5Q37702047-EBE67990-E366-4F79-86A9-B85A0978EFDA
P50
description
Noors onderzoeker
@nl
Norwegian researcher
@en
norsk forsker
@nb
taighdeoir Ioruach
@ga
name
Bjørn Naume
@ast
Bjørn Naume
@da
Bjørn Naume
@de
Bjørn Naume
@en
Bjørn Naume
@es
Bjørn Naume
@fr
Bjørn Naume
@ga
Bjørn Naume
@nb
Bjørn Naume
@nl
Bjørn Naume
@nn
type
label
Bjørn Naume
@ast
Bjørn Naume
@da
Bjørn Naume
@de
Bjørn Naume
@en
Bjørn Naume
@es
Bjørn Naume
@fr
Bjørn Naume
@ga
Bjørn Naume
@nb
Bjørn Naume
@nl
Bjørn Naume
@nn
prefLabel
Bjørn Naume
@ast
Bjørn Naume
@da
Bjørn Naume
@de
Bjørn Naume
@en
Bjørn Naume
@es
Bjørn Naume
@fr
Bjørn Naume
@ga
Bjørn Naume
@nb
Bjørn Naume
@nl
Bjørn Naume
@nn
P106
P21
P214
2134149068611865730001
P2287
P27
P31
P496
0000-0002-6811-9476
P735
P7859
viaf-2134149068611865730001